Showing 231-240 of 3231 results for "".
New SEO Trends Dermatologists Should Anticipate in 2021
https://practicaldermatology.com/topics/practice-management/new-seo-trends-dermatologists-should-anticipate-in-2021/19900/Dermatology online marketing will have a surge of possible business in 2021 as people start moving back to requesting and seeking medical care again, especially once COVID-19 vaccines become widespread. Getting ahead of the SEO search curve now will give your office the advantage before the demand mWhat's your Mobile Engagement Quotient?
https://practicaldermatology.com/topics/practice-management/meq/18486/Do you know your mobile engagement quotient? Do you even know what MEQ is? To connect with and expand your patient base, you need to enhance mobile engagement. Learn what you need to know in this Ekwa.com Marketing Educational video.The Male Aesthetic Patient: Who He Is and What He Needs
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/the-male-aesthetic-patient-who-he-is-and-what-he-needs/18701/Baby boomer men aren't necessarily driving the growth in male aesthetics. Terrence Keaney, MD says that millennial men in their 30s and 40s are most likely to seek treatments. In the initial consultation, education is essential so men understand the treatments offered and recognize that you understaCalming the Burn
https://practicaldermatology.com/topics/practice-management/calming-the-burn--fcwecwfe/18533/Physician burnout is a growing reality of today's healthcare landscape. Andrea Murina, MD talks about the problem, its increase, and its implications for dermatology. She also shares tips for finding balance.Advances in Treating NMSC
https://practicaldermatology.com/topics/skin-cancer-photoprotection/advances-in-treating-nmsc/18742/Dr. Goldenberg discusses the benefits of timed sequential therapy using two modalities — destructive therapy followed by field therapy — for actinic keratoses. He also talks about treatment options for advanced basal cell carcinoma, squamous cell carcinoma, and merkel cell carcinoma.Wondering with Steve and Sabrina: Mexico
https://practicaldermatology.com/topics/skin-cancer-photoprotection/wondering-with-steve-and-sabrina-mexico/18646/Traveling in the Baja Desert, Steven Dayan, MD and Sabrina Fabi, MD discover the benefits of Lomboy, a plant that can be used for sun protection. While natural isn't always better (think poison ivy), Lomboy is widely used to protect the skin because it produces a thick white paste. (C) Steven Dayan,Cellfina Cleared, Finacea Foam Approved
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-cellfina-cleared-finacea-foam-approved/18866/The FDA has cleared Cellfina (Ulthera Inc./Merz Aesthetics, Inc.) to treat cellulite, with results lasting for up to 2 years. Finacea Foam (azelaic acid, Bayer Dermatology) is approved for Rosacea, and Almirall invests in Suneva Medical, maker of Bellafill. Also in this edition, a look at the data oDermatopathology
https://practicaldermatology.com/topics/practice-management/dermatopathology/19104/Moderator Amy Derick, MD, Director of Derick Dermatology in Barrington, Crystal Lake, and Elgin, IL, talks about the relationship between dermatologists and dermatopathologists with Clay Cockerell, MD, Clinical Professor of Dermatology at UT Southwestern Medical Center in Dallas, TX. DermTube's coveSunscreen Water Seems All Washed Up; Fake Cosmeceuticals Raise Concerns
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-sunscreen-water-seems-all-washed-up-fake-cosmeceuticals-raise-concerns/19119/In this edition of DermWireTV, from the publishers of Practical Dermatology® magazine we take a look at drinkable sunscreen and school bans on sunscreens, get an update on Vegas Cosmetic Surgery, and meet the new face of AMBI skincare. Plus, our DermFocus investigates the problem of counterfeit cosDermWireTV: Olumiant Approved for AA; Radiesse + Launch; Derms as Influencers; VCS
https://practicaldermatology.com/topics/practice-management/dermwiretv-olumiant-approved-for-aa-radiesse-launch-derms-as-influencers-vcs/20107/Olumiant (baricitinib) from Eli Lilly and Company is approved to treat adult patients with severe alopecia areata. Dermatologists rank as top influencers of consumers’ decisions to have cosmetic procedures, according to results of the American Society for Dermatologic Surgery (ASDS) Consumer Survey